輸尿管金屬支架對於良性及惡性輸尿管梗阻應用之長期追蹤
許齡內1*、王弘仁1*、羅浩倫1、鄭元佐1、陳建旭1、李子瑜2、江博暉1
高雄長庚紀念醫院 外科部泌尿科1、放射科2
Application of resonance metallic stents for benign and malignant ureteral obstruction: long-term follow-up
Lin-Nei Hsu1*, Hung-Jen Wang1*, Hao-Lun Luo1, Yuao-Tso Cheng1, Chien-Hsu Chen1, Tze-Yu Lee2, and Po-Hui Chiang1
1 Department of Urology, Chang Gung Memorial Hospital – Kaohsiung medical center, Chang Gung University College of Medicine, Kaohsiung, Taiwan
2 Department of Radiology, Chang Gung Memorial Hospital – Kaohsiung medical center, Chang Gung University College of Medicine, Kaohsiung, Taiwan
* Dr. Hsu and Wang contribute equally to this manuscript and serve as co-first authors.
 
Purpose: To evaluate the outcomes of the metallic Resonance® ureteral stent and clarify the risk factors that lead to stent failure. In the present study, we present 5 years of our experiences with the use of a Resonance stent for malignant and benign ureteral obstruction.
Materials and Methods: We retrospectively identified and analyzed the records of all patients in whom Resonance® Metallic Ureteral Stent was placed between early 2009 and late 2014 in our hospital. We performed a descriptive analysis of key outcomes, including the failure and stenting duration, defined as the time from initial stent placement to last stent failure or patient death.
Results: A total of 52 metallic stents were placed in 36 patients, including 44 (84.6%) with malignant and 8 (15.4%) with a benign etiology. Maximum follow-up was 58 months (mean 14.7, median 8.5, IQR 14.9). Stent failure occurred in 10 patients (19.2%). The re-occlusion rate was significantly higher in the subgroup with urinary bladder invasion malignancy during Resonance stent insertion (p= 0.035). Patients who had had previous radiation therapy had a lower patency rate in comparison with non-radiation patients (p= 0.001), especially in patients with Resonance stent placement more than one year (p= 0.018). And the 50% patency rate with 52 stents was 10 months.
Conclusions: The Resonance metallic stent could be safely applied for those malignant or benign ureteral obstructions. For malignant ureteral obstruction, previous radiation therapy is a risk factor for stent failure, especially for those with long-term stent placement. We also suggested revision of Resonance metallic stent every one year to keep stent patency and prevent stent complications.
 
    位置
    資料夾名稱
    摘要
    發表人
    系統管理者
    單位
    台灣泌尿科醫學會
    標籤
    口頭報告
    建立
    2015-06-04 14:54:00
    最近修訂
    2015-06-04 14:55:11
    瀏覽
    1,382
    more